Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Nasal Fentanyl and Buccal Midazolam Give Better Symptom Control for Dying Patients When Compared With Standard Subcutaneous Medication? Pilot Randomised Controlled Trial and Qualitative Interview Study.

NCT02009306 is registered in ClinicalTrials.gov with Gloucestershire Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT02009306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02009306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Nasal Fentanyl and Buccal Midazolam Give Better Symptom Control for Dying Patients When Compared With Standard Subcutaneous Medication? Pilot Randomised Controlled Trial and Qualitative Interview Study.
Lead sponsor
Gloucestershire Hospitals NHS Foundation Trust
Phase
Phase 4
Overall status
Completed
Start date
January 23, 2017
Completion date
February 28, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

terminal cancer